3022-25: Pink Phoria

This presentation will provide a comprehensive overview of the new ketamine compound called Tusi. Nurses need to be cognizant about this new emerging substance and inquire about usage. Individuals need to be educated about the substances contained in Tusi and possible health complications.

Presenters:  Deborah Salani, DNP, APRN, PMHNP-BC, NE-BC; Deana Goldin, PhD, DNP, APRN, PMHNP-BC, FNP-BC

Disclosures:  The APNA planners and faculty have no relevant financial relationships to disclose. Off-label uses will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Understand the new ketamine compound Tusi.

Key Takeaway(s): 

• Tusi, sometimes referred to as '2C' or 'pink cocaine,' is a recently emerging ketamine-based drug in the U.S.
• Tusi ("2C") contains various psychoactive substances like ketamine, MDMA, LSD, fentanyl, xylazine and more.
• Components and dosages of Tusi vary widely, making its effects unpredictable and potentially dangerous.

Keywords:  Tusi (2C), Pink Cocaine, Party Drug

Nursing Continuing Professional Development:
0.75 pharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire presentation, complete the reflection activity, evaluation, and honor statement before the expiration date. Once all steps are successfully completed, a certificate will be generated online and available for you to print immediately. Contact hours cannot be awarded unless all required components are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Release Date:  December 15, 2025
Access to this course will end:  December 1, 2027

*For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.